S&P 500   4,238.67 (-1.16%)
DOW   33,093.22 (-1.02%)
QQQ   355.63 (-1.56%)
AAPL   172.00 (-1.01%)
MSFT   313.79 (-2.49%)
META   300.69 (-2.00%)
GOOGL   132.75 (-1.06%)
AMZN   125.29 (-3.22%)
TSLA   248.80 (-1.11%)
NVDA   438.63 (-2.05%)
NIO   8.70 (-1.02%)
BABA   84.78 (-2.02%)
AMD   100.65 (-2.54%)
T   14.60 (-0.48%)
F   12.12 (-1.54%)
MU   68.30 (+0.50%)
CGC   0.70 (-5.05%)
GE   107.60 (-1.09%)
DIS   79.77 (-2.33%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.74 (-1.40%)
NFLX   378.30 (-0.53%)
S&P 500   4,238.67 (-1.16%)
DOW   33,093.22 (-1.02%)
QQQ   355.63 (-1.56%)
AAPL   172.00 (-1.01%)
MSFT   313.79 (-2.49%)
META   300.69 (-2.00%)
GOOGL   132.75 (-1.06%)
AMZN   125.29 (-3.22%)
TSLA   248.80 (-1.11%)
NVDA   438.63 (-2.05%)
NIO   8.70 (-1.02%)
BABA   84.78 (-2.02%)
AMD   100.65 (-2.54%)
T   14.60 (-0.48%)
F   12.12 (-1.54%)
MU   68.30 (+0.50%)
CGC   0.70 (-5.05%)
GE   107.60 (-1.09%)
DIS   79.77 (-2.33%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.74 (-1.40%)
NFLX   378.30 (-0.53%)
S&P 500   4,238.67 (-1.16%)
DOW   33,093.22 (-1.02%)
QQQ   355.63 (-1.56%)
AAPL   172.00 (-1.01%)
MSFT   313.79 (-2.49%)
META   300.69 (-2.00%)
GOOGL   132.75 (-1.06%)
AMZN   125.29 (-3.22%)
TSLA   248.80 (-1.11%)
NVDA   438.63 (-2.05%)
NIO   8.70 (-1.02%)
BABA   84.78 (-2.02%)
AMD   100.65 (-2.54%)
T   14.60 (-0.48%)
F   12.12 (-1.54%)
MU   68.30 (+0.50%)
CGC   0.70 (-5.05%)
GE   107.60 (-1.09%)
DIS   79.77 (-2.33%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.74 (-1.40%)
NFLX   378.30 (-0.53%)
S&P 500   4,238.67 (-1.16%)
DOW   33,093.22 (-1.02%)
QQQ   355.63 (-1.56%)
AAPL   172.00 (-1.01%)
MSFT   313.79 (-2.49%)
META   300.69 (-2.00%)
GOOGL   132.75 (-1.06%)
AMZN   125.29 (-3.22%)
TSLA   248.80 (-1.11%)
NVDA   438.63 (-2.05%)
NIO   8.70 (-1.02%)
BABA   84.78 (-2.02%)
AMD   100.65 (-2.54%)
T   14.60 (-0.48%)
F   12.12 (-1.54%)
MU   68.30 (+0.50%)
CGC   0.70 (-5.05%)
GE   107.60 (-1.09%)
DIS   79.77 (-2.33%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.74 (-1.40%)
NFLX   378.30 (-0.53%)
NASDAQ:SGEN

Seagen (SGEN) Price Target & Analyst Ratings

$212.04
+0.30 (+0.14%)
(As of 12:10 PM ET)
Compare
Today's Range
$211.60
$212.50
50-Day Range
$191.57
$216.16
52-Week Range
$116.08
$217.08
Volume
433,818 shs
Average Volume
1.37 million shs
Market Capitalization
$39.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$190.47

Seagen Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 17 Analyst Ratings

Consensus Analyst Price Target

$190.47
-10.17% Downside
High Prediction$229.00
Average Prediction$190.47
Low Prediction$129.00
TypeCurrent
10/3/22 to 10/3/23
1 Month Ago
9/3/22 to 9/3/23
3 Months Ago
7/5/22 to 7/5/23
1 Year Ago
10/3/21 to 10/3/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
9 Buy rating(s)
Hold
11 Hold rating(s)
11 Hold rating(s)
11 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$190.47$190.47$190.47$180.36
Predicted Upside-10.17% Downside10.66% Upside10.40% Upside13.30% Upside
Get Seagen Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter.


SGEN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SGEN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Seagen Stock vs. The Competition

TypeSeagenMedical CompaniesS&P 500
Consensus Rating Score
2.35
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside-10.04% Downside842.35% Upside698.27% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/25/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Hold$229.00+7.16%
8/3/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$229.00+18.35%
4/28/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$157.00 ➝ $229.00+13.90%
3/24/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
3/21/2023TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform$145.00 ➝ $129.00-35.66%
3/14/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Market Perform$179.00 ➝ $229.00+14.59%
3/14/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$155.00 ➝ $229.00+15.86%
3/14/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$141.00 ➝ $229.00+15.86%
3/14/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$210.00 ➝ $229.00+15.86%
3/14/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$145.00 ➝ $228.00+15.36%
3/14/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
3/13/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
3/13/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeStrong-Buy ➝ Market Perform
2/28/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$170.00-4.27%
2/16/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$180.00+10.75%
2/16/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$140.00 ➝ $175.00+23.20%
2/13/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$154.00 ➝ $150.00+7.99%
2/6/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Andrew Berens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$162.00 ➝ $141.00+2.17%
11/1/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$145.00+14.45%
(Data available from 10/3/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SGEN Price Target - Frequently Asked Questions

What is Seagen's consensus rating and price target?

According to the issued ratings of 17 analysts in the last year, the consensus rating for Seagen stock is Hold based on the current 11 hold ratings and 6 buy ratings for SGEN. The average twelve-month price prediction for Seagen is $190.47 with a high price target of $229.00 and a low price target of $129.00. Learn more on SGEN's analyst rating history.

Do Wall Street analysts like Seagen more than its competitors?

Analysts like Seagen less than other Medical companies. The consensus rating for Seagen is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how SGEN compares to other companies.

Does Seagen's stock price have much upside?

According to analysts, Seagen's stock has a predicted upside of 8.77% based on their 12-month price targets.

What analysts cover Seagen?

Seagen has been rated by Morgan Stanley, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:SGEN) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -